Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Mulet, Nuria
106  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

A randomised phase 2 study comparing different dose approac..:

Argilés, Guillem ; Mulet, Nuria ; Valladares-Ayerbes, Manuel...
info:eu-repo/semantics/altIdentifier/pmid/36335783.  , 2022
Link: https://hdl.handle.net/1..
 
?
2

A randomised phase 2 study comparing different dose approac..:

Argilés, Guillem ; Mulet, Nuria ; Valladares-Ayerbes, Manuel...
http://hdl.handle.net/10668/22181.  , 2022
Link: http://hdl.handle.net/10..
 
?
3

A randomised phase 2 study comparing different dose approac..:

Argilés, Guillem ; Mulet, Nuria ; Valladares Ayerbes, Manuel...
Reproducció del document publicat a: https://doi.org/10.1016/j.ejca.2022.09.037.  , 2022
Link: http://hdl.handle.net/24..
 
?
4

BRAF, MEK and EGFR inhibition as treatment strategies in BR..:

Ros, Javier ; Baraibar, Iosune ; Sardo, Emilia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903827/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
5

Molecular subtypes and the evolution of treatment managemen..:

Martini, Giulia ; Dienstmann, Rodrigo ; Ros, Javier...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383645/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
6

Impact of circulating tumor DNA mutant allele fraction on p..:

Elez, Elena ; Chianese, Chiara ; Sanz-García, Enrique...
Instituto de Salud Carlos III PI12-01589.  , 2019
Link: https://ddd.uab.cat/reco..
 
?
7

Genomically matched therapy in refractory colorectal cancer..:

Mulet Margalef, Núria ; Castillo, Carmen ; Mosteiro, Miguel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483603/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
8

Meta-Analysis and Validation of a Colorectal Cancer Risk Pr..:

Obón Santacana, Mireia ; Mas Lloret, Joan ; Bars Cortina, David...
Reproducció del document publicat a: https://doi.org/10.3390/cancers14174214.  , 2022
Link: http://hdl.handle.net/24..
 
?
9

A randomised phase 2 study comparing different dose approac..:

Argilés Martinez, Guillem ; Mulet Margalef, Nuria ; Valladares-Ayerbes, Manuel...
European Journal of Cancer;177.  , 2022
Link: https://hdl.handle.net/1..
 
?
10

A Comprehensive Biomarker Analysis of Microsatellite Unstab..:

Elez Fernandez, Mª Elena ; Mulet Margalef, Núria ; Sanso Martinez, Miriam...
International Journal of Molecular Sciences;24(1).  , 2022
Link: https://hdl.handle.net/1..
 
?
11

BRAF, MEK and EGFR inhibition as treatment strategies in BR..:

Ros Montañá, Fco. Javier ; Baraibar Argota, Iosune ; Sardo, Emilia...
Therapeutic Advances in Medical Oncology;13.  , 2021
Link: https://hdl.handle.net/1..
 
?
12

Tumor-Associated Microbiome: Where Do We Stand?:

Oliva, Marc ; Mulet Margalef, Núria ; Ochoa de Olza, Maria...
Reproducció del document publicat a: https://doi.org/10.3390/ijms22031446.  , 2021
Link: http://hdl.handle.net/24..
 
?
13

and inhibition as treatment strategies in V600E metastatic ..:

Javier Ros ; Iosune Baraibar ; Emilia Sardo...
https://doi.org/10.1177/1758835921992974.  , 2021
Link: https://doi.org/10.1177/..
 
?
14

Tumor-Associated Microbiome: Where Do We Stand?:

Oliva, Marc ; Mulet Margalef, Núria ; Ochoa de Olza Amat, Maria...
International Journal of Molecular Sciences;22(3).  , 2021
Link: https://hdl.handle.net/1..
 
?
15

Factores predictivos de respuesta a inmunoterapia en cáncer..:

Mulet Margalef, Núria
Programa de Doctorat en Medicina.  , 2021
Link: https://ddd.uab.cat/reco..
 
1-15